Psoria-Light® is first-to-market Targeted Deep NB - UVB/UVA LED Phototherapy device
SCHAUMBURG, Ill., June 08, 2015 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc. (OTCQB:WCUI) today announced that its wholly-owned subsidiary, Psoria-Shield, Inc. (PSI), has entered into a purchasing and distribution agreement with Medcomp Services, LLC (MCS), a leading specialist in providing innovative medical technology and products, as well as digital based marketing initiatives to focused practices such as Dermatologists, Plastic Surgeons, and Physician Owned Medical Spas. The basis of the agreement will provide for multi-unit purchases of PSI’s targeted phototherapy device, Psoria-Light®. Under the terms of the Agreement, product delivery will commence this month.
Medcomp Services, LLC will purchase several Psoria-Light® units for its own use as well as distribute the device to its client base of Physicians, Plastic Surgeons, and Medical Spas. Additionally, Medcomp Services, LLC will use its sales and marketing personnel to provide education and training on Psoria-Light® to its clients. Certain MCS clients in the NYC area are: Beauty Fix Medspa, Body Cosmetica, Allgenic, and more.
“We are excited to be entering into this sales, marketing, and distribution agreement with Psoria-Shield, Inc.,” stated Mark Greenspan, principal of Medcomp Services, LLC. “Our network of physicians who purchase Psoria-Light® will be able to treat and provide relief to a large population of patients suffering from skin disorders such as eczema, psoriasis, and vitiligo,” he added.
With the Psoria-Light®, physicians will be able to offer their patients the most advanced NB - UVB/UVA LED treatment available today. This FDA cleared procedure is recognized by many major insurance companies as well as government agencies. Third party awareness organizations, policy makers, and insurers are becoming increasingly aware of the cost benefit of UV phototherapy (targeted or non-targeted) to the patient and the healthcare system as opposed to systemic/biologic drug therapy. The short and long term impact on healthcare system costs associated with systemic/biologic drug side effects can be substantial.
“This Agreement will provide exposure and introduce PSI to the leading dermatological practices in the metro NYC area. Over the last decade, I have observed first-hand the marketing success the group, its principal, and its affiliates have had selling capital medical products to physicians. The superiority of our Psoria-Light® system coupled with the track record of the personnel involved will provide us with significant market penetration," stated John Yorke, Managing Director of Psoria Development Company, LLC (PDC) and The Medical Alliance (TMA). “Minimally, this relationship with MCS will generate $450-$500k in sales for PSI this year," continued Yorke.
As reported by The Telegraph on May 26, 2015 (to view the full article, click here), Amgen’s departure from its partnership with AstraZeneca after their highly talked about brodalumab psoriasis and psoriasis arthritis treatment was found to cause suicidal thoughts in patients, suggests that the need for safer treatment solutions such as the Psoria-Light® will become even greater. “The Psoria-Light® has an unquestioned track record of being the safest, most effective and economical option available today,” stated Dr. Seth Forman, Medical Director of Forman Dermatology and Psoria-Shield, Inc.
Further, the article states that over 125 million people worldwide, or one in 50 adults, have psoriasis, including famous model Cara Delevingne, and reality TV star Kim Kardashian, who has been vocal about her struggles with the disease.
About Wellness Center USA, Inc.
Wellness Center USA, Inc. (www.wellnesscenterusa.com) is a hybrid healthcare company that combines best in class technologies, software, devices, providers, protocols, goods, and services. It was created to address important healthcare and wellness needs via breakthrough solutions, all centered around the “well-being of the body and mind." Wellness Center USA, Inc. is the parent company of three businesses reporting consolidated: Stealth Mark, National Pain Centers, and Psoria-Shield.
About Medcomp Services, LLC.
Medcomp Services, LLC (www.medcompgroup.com) specializes in providing innovative medical technology and products, as well as digital-based and management initiatives to focused practices such as Dermatologists, Plastic Surgeons, and Physician owned Medical Spas. MCS’s success is the result of its ability to integrate its knowledge of NYC based physicians/practices with sales entities that sell or market specialized medical products to targeted markets in the NYC area ie: Beauty Fix Medspa, Body Cosmetica, Allgenic, and more.
Safe Harbor Statement:
Certain statements and projections contained in this presentation that are not statements or financial results of historical fact constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements and projections include statements regarding any proposed exchange transactions, the anticipated closing date of such transactions and future results following a closing of the transactions. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts. They often include words like “believe,” “expect,” “anticipate,” “pending," “estimate,” and “intend” or future or conditional verbs such as “will,” “would,” “should,” “could,” or “may.” While it is not possible to identify all factors, risks and uncertainties that might relate to, affect or arise from the proposed transactions and plans which might cause actual results to differ materially from expected results, such factors, risks and uncertainties include delays in completing the transactions, difficulties in integrating operations following the transactions, difficulties in manufacturing and delivering products, potential market rejection of products or services, increased competitive pressures, changes in general economic conditions, legislative and regulatory changes that adversely affect the business in which the parties are engaged, changes in the securities markets and other factors, risks and uncertainties disclosed from time to time in documents that the Company files with the SEC.